The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.

《Expert Review Of Gastroenterology & Hepatology》是一本由TAYLOR & FRANCIS LTD出版商出版的专业医学期刊，该刊创刊于2007年，刊期8 issues/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：胃肠肝病学 4区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖胃肠肝病学等领域，旨在及时、准确、全面地报道国内外胃肠肝病学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为4.095，平均审稿速度较慢,6-12周。